U.S. Semiconductors Stock News

NYSE:CVI
NYSE:CVIOil and Gas

Is It Time To Reassess CVR Energy (CVI) After The Recent Share Price Pullback?

Wondering whether CVR Energy at around US$30.18 still offers value, or if the easy gains are behind it? This article walks through what the recent performance and current pricing might be telling you. The stock has seen a 3.6% decline over the last 7 days and a 10.8% decline over the last 30 days, even though the year to date return is 19.8% and the 1 year return sits at 65.4%. Those moves come after a multi year run in which the 3 year return is 30.9% and the 5 year return is 211.0%. These...
NasdaqGS:CHKP
NasdaqGS:CHKPSoftware

Is It Time To Revisit Check Point Software Technologies (CHKP) After A 33% One-Year Share Price Fall

Wondering whether Check Point Software Technologies at around US$138 still lines up with what you think it is worth? This article walks through what the current price might be implying about the stock's value. The share price has recently closed at US$138.15, with returns of a 2.8% decline over 7 days, 9.5% decline over 30 days, 23.7% decline year to date, and 33.4% decline over the last year, compared to gains of 5.5% over 3 years and 17.7% over 5 years. These moves have arrived alongside...
NYSE:QXO
NYSE:QXOTrade Distributors

Is QXO (QXO) Offering Value After 90% One Year Share Price Surge?

Wondering whether QXO at around US$24.22 is offering value or asking too much of future expectations? This breakdown is designed to help you weigh that up calmly and clearly. The stock has shown sharp moves recently, with returns of 9.1% over 7 days, 29.9% over 30 days, 22.8% year to date, 90.4% over 1 year, 18.4% over 3 years, and a 38.4% decline over 5 years. These mixed returns give important context for thinking about what investors are currently pricing in and how sentiment toward QXO...
NYSE:FE
NYSE:FEElectric Utilities

Is It Too Late To Consider FirstEnergy (FE) After Strong 1 Year Share Price Gain?

How FirstEnergy’s Recent Returns Frame the Valuation Question Before comparing valuation models, it helps to see how FirstEnergy’s share price has behaved over different time frames and what that might signal about how the market currently views the company. Over the last year, FirstEnergy has returned 23.1%, with a year to date return of 9.3%. The shorter term picture is more mixed, with a 1.9% return over the last 30 days and a 3.1% decline over the last week, which can be relevant if you...
NasdaqGS:WASH
NasdaqGS:WASHBanks

Washington Trust Bancorp Q1 Profitability Recovery Reinforces Bullish Narratives On Earnings Quality

Washington Trust Bancorp (WASH) opened 2026 with Q1 revenue of US$53.8 million and basic EPS of US$0.66, alongside trailing twelve month revenue of US$215.8 million and EPS of US$2.75 that reflect a return to profit. Over recent quarters the company has seen revenue move from US$57.9 million in Q1 2025 to US$53.8 million in Q1 2026, while quarterly EPS has ranged between US$0.57 and US$0.84. This gives investors a clearer read on how current margins are holding up against last year’s...
NYSE:EBF
NYSE:EBFCommercial Services

Ennis (EBF) Q3 EPS Slowdown Tests Bullish Earnings Growth Narratives

Ennis (EBF) has just wrapped up its latest quarter with Q3 FY 2026 revenue of US$100.2 million, basic EPS of US$0.43 and net income of US$10.8 million, setting the tone for how the rest of the fiscal year is shaping up. The company has seen quarterly revenue move from US$92.7 million in Q4 FY 2025 to US$100.2 million in Q3 FY 2026. Over the same stretch, basic EPS ranged from US$0.35 to US$0.51, giving investors a clear view of how the top and bottom lines are tracking into FY 2026 and what...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Robotics Milestone And New Tech Leadership Spark Valuation Questions

Zimmer Biomet Holdings (NYSE:ZBH) supported the nation’s first complete robotic assisted shoulder replacement in an ambulatory surgery center. The company appointed Dr. Jonathan M. Vigdorchik as Chief Science, Technology, and Medical Affairs Officer to oversee AI, robotics, and smart implant efforts. Zimmer Biomet enters this news cycle with shares at $95.48 and mixed long term returns. The stock is up 8.7% over the past 30 days and 6.1% year to date, while the 3 year and 5 year returns...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line Revisits Philadelphia With Homeport And Valuation Questions

Norwegian Cruise Line Holdings (NYSE:NCLH) is returning to Philadelphia with new homeport sailings for the first time in 15 years. The company plans to introduce year round itineraries from the city, supported by investment in a new cruise terminal. This move expands Norwegian’s presence in the Mid Atlantic region and opens access to additional source markets along the US East Coast. Norwegian Cruise Line Holdings operates global cruise brands that compete for vacation spending against...
NYSE:BOH
NYSE:BOHBanks

Bank Of Hawaii (BOH) Net Margin Rebound Challenges Longstanding Earnings Decline Narrative

Bank of Hawaii (BOH) opened Q1 2026 earnings season on a solid footing, with Q4 2025 revenue at US$187.1 million and basic EPS of US$1.40 backed by net income of US$55.7 million and a trailing twelve month earnings increase of 34.6%. Over recent quarters, revenue has moved from US$159.5 million in Q4 2024 to US$187.1 million in Q4 2025. Basic EPS has shifted from US$0.86 to US$1.40, against a backdrop of a higher net profit margin of 26.2% over the last 12 months versus 21.9% previously. For...
OTCPK:FMBL
OTCPK:FMBLBanks

Farmers & Merchants Bank (OTCPK:FMBL) Net Interest Margin Rise Tests Bearish Narratives

Farmers & Merchants Bank of Long Beach (FMBL) has opened Q1 2026 earnings season with recent quarterly numbers that include Q4 2025 total revenue of US$79.1 million and basic EPS of US$160, alongside trailing 12 month EPS of about US$560 on revenue of US$293.2 million. Over recent quarters the bank has seen revenue move from US$56.6 million in Q4 2024 to US$79.1 million in Q4 2025 and quarterly EPS shift from about US$32 in Q4 2024 to roughly US$160 in Q4 2025, with net income excluding extra...
OTCPK:STLE
OTCPK:STLEBanks

Steele Bancorp (OTCPK:STLE) One Off US$12.8m Gain Reshapes Earnings Narrative

Steele Bancorp (OTCPK:STLE) has just posted Q1 2026 results with Q4 2025 numbers showing total revenue of US$13.5 million and basic EPS of US$1.64, capping off a trailing twelve month period where reported earnings grew 410.8%. Over the last year, total revenue has moved from US$4.59 million in Q4 2024 to US$13.5 million in Q4 2025, while trailing EPS climbed from US$2.41 to US$9.15, with much of that uplift tied to a one off US$12.8 million gain and a net profit margin that now sits at...
NYSE:ALV
NYSE:ALVAuto Components

Autoliv Broadens Airbag Reach As Asian Growth And Valuation Gap Stand Out

Autoliv (NYSE:ALV) is expanding beyond traditional car airbags into motorcycle and wearable airbag safety products. The company has introduced its first motorcycle airbag and wearable airbag solutions, targeting riders and other vulnerable road users. Autoliv has recently outperformed in Asian markets such as China, India, and South Korea alongside this product expansion. Autoliv, trading around $121.36, is increasingly tied to broader mobility safety rather than just passenger vehicles...
NYSE:TPC
NYSE:TPCConstruction

Is It Too Late To Consider Tutor Perini (TPC) After A 327% One-Year Surge?

If you are wondering whether Tutor Perini at around US$84 is still priced attractively after a strong run, you are not alone. That is exactly what this valuation focused review will unpack. The stock has posted returns of 0.7% over the last week, 21.7% over the last month, 21.7% year to date and 327.1% over the past year. This naturally raises questions about how much value is already reflected in the share price. Recent headlines around Tutor Perini have centered on the company winning and...
NasdaqGM:NNOX
NasdaqGM:NNOXHealthcare

Nano X Imaging (NNOX) Quarterly Losses Far Exceed US$3.4m Revenue Reinforcing Bearish Narratives

Nano-X Imaging (NNOX) has reported third quarter FY 2025 revenue of US$3.4 million with a basic EPS loss of US$0.21, alongside trailing twelve month revenue of US$12.3 million and a basic EPS loss of US$0.88. The company has seen quarterly revenue move from US$2.7 million in Q2 2024 to US$3.4 million in Q3 2025, while basic EPS has remained in a narrow loss range between roughly US$0.21 and US$0.23 per quarter. This keeps the focus on whether revenue can outgrow persistent losses and...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

If You Believe In Robotics And Automation Stocks Then These Three Trajectories Could Define The Next Cycle

Robotics is moving from science project to real-world workhorse just as investors are juggling inflation worries, oil-price swings, and changing interest rate expectations across major economies. While bond yields, energy markets, and central bank signals keep shifting, the physical AI push is quietly about one thing you can understand very clearly: productivity. This screener focuses on robotics companies that are not just building hardware, but are structured to translate automation demand...
NasdaqCM:MNSB
NasdaqCM:MNSBBanks

MainStreet Bancshares (MNSB) Net Interest Margin Resilience Tests Bullish Narratives In Q1 2026

MainStreet Bancshares (MNSB) has followed up its move back into profitability with Q1 2026 results that sit against a recent run of steady quarterly revenue and earnings, capped most recently by Q4 2025 revenue of about US$17.7 million and basic EPS of US$0.46 on net income of US$3.5 million. Over the last few quarters, the company has seen total revenue move from US$13.3 million in Q3 2024 to US$17.4 million in Q1 2025 and then to US$17.7 million in Q4 2025. Over the same period, quarterly...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Is Cooper Companies (COO) Now Attractive After Recent Share Price Weakness?

If you are wondering whether Cooper Companies is starting to look better value after a weaker share price, this article walks through the key numbers that matter to you. The stock last closed at US$69.46, with returns of a 3.1% decline over 7 days, a 0.7% decline over 30 days, a 14.4% decline year to date, and an 11.7% decline over 1 year. These moves may have changed how some investors view its risk and opportunity profile. Recent coverage has focused on Cooper Companies within the broader...
NasdaqGM:ISTR
NasdaqGM:ISTRBanks

Investar Holding (ISTR) Rising Net Interest Margin Reinforces Bullish Profitability Narratives

Investar Holding (ISTR) has just put fresh numbers on the table for Q1 2026, with recent quarters showing total revenue stepping from US$20.2 million in Q4 2024 to US$23.2 million in Q4 2025 and quarterly EPS ranging between about US$0.46 and US$0.64 over 2025. Over the same period, trailing twelve month EPS moved from US$2.06 to US$2.22 while revenue on this basis went from US$83.2 million to US$93.3 million, giving investors a clear line of sight on how the top line and per share earnings...
NasdaqGS:CCBG
NasdaqGS:CCBGBanks

Capital City Bank Group (CCBG) Net Margin Near 25% Reinforces Bullish Earnings Narratives

Capital City Bank Group (CCBG) has just closed out Q4 2025 with total revenue of US$61.5 million and net income of US$13.7 million, translating into basic EPS of US$0.80 as the latest marker of its earnings run into Q1 2026. Over recent quarters the bank has seen revenue move from US$58.5 million in Q3 2024 to US$61.5 million in Q4 2025, while EPS has ranged between roughly US$0.77 and US$0.99, giving investors a clear view of how top line and per share profit have tracked together. Set...
NYSE:DX
NYSE:DXMortgage REITs

Dynex Capital (DX) Net Margin Surge Tests Bearish Cash Flow Concerns

Dynex Capital (DX) has just reported new figures, with recent quarters showing total revenue moving from US$60.3 million in Q4 2024 to US$202.0 million in Q4 2025 and basic EPS shifting from US$0.61 to US$1.17 over the same period, alongside trailing 12 month net income of US$308.9 million. Over the past year, revenue has tracked from US$150.4 million on a trailing basis in Q4 2024 to US$372.1 million by Q4 2025, while trailing EPS has moved from US$1.50 to US$2.49. These figures provide a...
NasdaqGS:PCRX
NasdaqGS:PCRXPharmaceuticals

A Look At Pacira BioSciences (PCRX) Valuation After New EXPAREL Health Economic Data

Pacira BioSciences (PCRX) shares recently reacted to fresh health economic data on its flagship non opioid pain drug, EXPAREL, following presentations at the Academy of Managed Care Pharmacy Annual 2026 Meeting in Nashville. See our latest analysis for Pacira BioSciences. The new EXPAREL health economic data arrives alongside a 90 day share price return of 28.08% and a 30 day share price return of 11.80%. However, the 1 year total shareholder return of 4.56% and 5 year total shareholder...
NYSE:MAX
NYSE:MAXInteractive Media and Services

April 2026's Top Growth Stocks With Strong Insider Ownership

The United States market has experienced a robust performance, climbing 4.0% in the last week and 39% over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with strong insider ownership can be particularly appealing as they often indicate confidence from those closest to the business, aligning well with current market optimism.
NYSE:AIV
NYSE:AIVResidential REITs

Promising Penny Stocks To Watch In April 2026

The market has climbed 4.0% in the last 7 days and 39% over the past year, with earnings forecast to grow by 16% annually. Though often considered outdated, penny stocks still hold potential when supported by robust financials, offering opportunities that larger firms might overlook. We'll explore several penny stocks that stand out for their financial strength and potential for growth, appealing to investors looking for under-the-radar opportunities.